Neurobiology of Disease

Microarray Applications in Neuroscience
pp. 183-193(11)
Authors: Luo Z.; Geschwind D.H.

Caspase-Mediated Suppression of Glutamate (AMPA) Receptor Channel Activity in Hippocampal Neurons in Response to DNA Damage Promotes Apoptosis and Prevents Necrosis: Implications for Neurological Side Effects of Cancer Therapy and Neurodegenerative Disorders
pp. 194-206(13)
Authors: Lu C.; Fu W.; Mattson M.P.

Early Neurodegeneration after Hypoxia-Ischemia in Neonatal Rat Is Necrosis while Delayed Neuronal Death Is Apoptosis
pp. 207-219(13)
Authors: Northington F.J.; Ferriero D.M.; Graham E.M.; Traystman R.J.; Martin L.J.

Alterations in Cortical and Basal Ganglia Levels of Opioid Receptor Binding in a Rat Model of l-DOPA-Induced Dyskinesia
pp. 220-239(20)
Authors: Johansson P.A.; Andersson M.; Andersson K.E.; Cenci M.A.

Death of Motoneurons Induced by Trophic Deprivation or by Excitotoxicity Is Not Prevented by Overexpression of SMN
pp. 240-251(12)
Authors: Cisterni C.; Kallenbach S.; Jordier F.; Bagnis C.; Pettmann B.

Complement Association with Neurons and -Amyloid Deposition in the Brains of Aged Individuals with Down Syndrome
pp. 252-265(14)
Authors: Head E.; Azizeh B.Y.; Lott I.T.; Tenner A.J.; Cotman C.W.; Cribbs D.H.

The Protein 4.1 Tumor Suppressor, DAL-1, Impairs Cell Motility, But Regulates Proliferation in a Cell-Type-Specific Fashion
pp. 266-278(13)
Authors: Gutmann D.H.; Hirbe A.C.; Huang Z-y.; Haipek C.A.

Primary Myopathy and Accumulation of PrP^Sc-Like Molecules in Peripheral Tissues of Transgenic Mice Expressing a Prion Protein Insertional Mutation
pp. 279-288(10)
Authors: Chiesa R.; Pestronk A.; Schmidt R.E.; Tourtellotte W.G.; Ghetti B.; Piccardo P.; Harris D.A.

Enhanced Proliferation of Lymphoblasts from Patients with Alzheimer Dementia Associated with Calmodulin-Dependent Activation of the Na⁺/H⁺ Exchanger
pp. 289-298(10)
Authors: Urcelay E.; Ibarreta D.; Parrilla R.; Ayuso M.S.; Martín-Requero A.

Sublethal Concentrations of Prion Peptide PrP106–126 or the Amyloid Beta Peptide of Alzheimer's Disease Activates Expression of Proapoptotic Markers in Primary Cortical Neurons
pp. 299-316(18)
Authors: White A.R.; Guirguis R.; Brazier M.W.; Jobling M.F.; Hill A.F.; Beyreuther K.; Barrow C.J.; Masters C.L.; Collins S.J.; Cappai R.

Genetic Analysis of Synphilin-1 in Familial Parkinson's Disease
pp. 317-323(7)
Authors: Farrer M.; Destée A.; Levecque C.; Singleton A.; Engelender S.; Becquet E.; Mouroux V.; Richard F.; Defebvre L.; Crook R.; Hernandez D.; Ross C.A.; Hardy J.; Amouyel P.; Chartier-Harlin M-C.

Prion Protein Affects Ca²⁺-Activated K⁺ Currents in Cerebellar Purkinje Cells
pp. 324-330(7)
Authors: Herms J.W.; Tings T.; Dunker S.; Kretzschmar H.A.

Alzheimer's Disease-like Alterations in Peripheral Cells from Presenilin-1 Transgenic Mice
pp. 331-342(12)
Authors: Eckert A.; Schindowski K.; Leutner S.; Luckhaus C.; Touchet N.; Czech C.; Müller W.E.

Upregulation of Striatal Preproenkephalin Gene Expression Occurs before the Appearance of Parkinsonian Signs in 1-Methyl-4-phenyl- 1,2,3,6-tetrahydropyridine Monkeys
pp. 343-350(8)
Authors: Bezard E.; Ravenscroft P.; Gross C.E.; Crossman A.R.; Brotchie J.M.

Seasonal Affective Disorder and Serotonin-Related Polymorphisms
pp. 351-357(7)
Authors: Johansson C.; Smedh C.; Partonen T.; Pekkarinen P.; Paunio T.; Ekholm J.; Peltonen L.; Lichtermann D.; Palmgren J.; Adolfsson R.; Schalling M.

Volume 7, Number 6 (2000) in the article “Cellular Expression of 7 Nicotinic Acetylcholine Receptor Protein in the Temporal Cortex in Alzheimer's and Parkinson's Disease—A Stereological Approach,” by Carolin Banerjee, Jens R. Nyengaard, Andrea Wevers, Rob A. I. de Vos, Ernst N. H. Jansen Steur, Jon Lindstrom, Kirsten Pilz, Sonja Nowacki, Wilhelm Bloch, and Hannsjörg Schröder, pages 666–672 (doi:10.1006/nbdi.2000.0317)
pp. 358-358(1)